期刊文献+

甘油三酯对经皮冠状动脉介入术后患者预后的预测价值 被引量:2

下载PDF
导出
摘要 目的:研究血脂因素对经皮冠状动脉介入(PCI)术后低密度脂蛋白胆固醇(LDL-C)达标患者出现主要不良心脏事件(MACE)的预测价值。方法:112例PCI术后患者,术后强化降脂并使得LDL-C水平达标,根据是否出现主要不良心脏事件分为MACE(-)组和MACE(+)组。于PCI术前及随访期分别留取外周血标本,检测甘油三酯、总胆固醇、LDL-C和高密度脂蛋白胆固醇等血液指标。采用SPSS13.0软件对各个指标进行统计学分析。结果:随访期内约11.61%患者出现主要不良心脏事件,单因素分析显示MACE(+)组患者甘油三酯和血糖水平高于MACE(-)组;多因素Logistic回归分析显示甘油三酯是主要不良心脏事件的危险因素。结论:血清甘油三酯可能是PCI术后LDL-C达标患者发生主要不良心脏事件的预测因素之一。
出处 《实用医学杂志》 CAS 北大核心 2010年第16期2989-2991,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献11

  • 1郑刚.他汀类药物对老年心血管病患者应用研究进展[J].中华老年心脑血管病杂志,2008,10(11):867-869. 被引量:3
  • 2O'Keefe J H Jr, Cordain L, Harris W H, et al. Optimal lowdensity lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal [J]. J Am Coll Cardiol, 2004,43 (11): 2142-2146.
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 4Baigent C, Keech A, Kearney P M, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J]. Lancet, 2005,366(9493) : 1267-1278.
  • 5Miller M, Ginsberg H N, Schaefer E J. Relative atherogenicity and predictive value of non-hlgh-density lipoprotein cholesterol for coronary heart disease [J]. Am J Cardiol, 2008,101 (7) : 1003-1008.
  • 6邓宏伟,刘伟波,李启锡,林珍.氟伐他汀早期治疗急性冠脉综合征的疗效观察[J].实用医学杂志,2008,24(13):2319-2320. 被引量:3
  • 7Grundy S M, Cleeman J I, Merz C N, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines [J]. J Am Coll Cardiol, 2004,44(3) :720-732.
  • 8武阳丰,赵冬,周北凡,王薇,李贤,刘静,李莹,孙佳艺,赵连成,吴兆苏,诸骏仁.中国成人血脂异常诊断和危险分层方案的研究[J].中华心血管病杂志,2007,35(5):428-433. 被引量:175
  • 9Gandotra P, Miller M. The role of triglycerides in cardiovascular risk [J]. Curr Cardiol Rep, 2008,10(6) :505-511.
  • 10Miller M, Cannon C P, Murphy S A, et al. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial [J]. J Am Coil Cardiol, 2008,51 (7) : 724-730.

二级参考文献174

共引文献5347

同被引文献17

  • 1Austin MA. Epidemiology of hypertriglyceridemia and cardiovas- cular disease. Am J Cardiol, 1999,83:13F-16F.
  • 2Matt D, Seheffel H, Leschka S, et al. Dual-source CT coronary angiography: image quality, mean heart rate, and heart rate vari- ability. AJR, 2007, 189:567-573.
  • 3Brodoefel H, Reimann A, Heuschmid M, et al. Characterization of coronary atherosclerosis by dual-source computed tomography and HU-based color mapping: a pilot study. Eur Radiol, 2008, 18:2466-2474.
  • 4Miller M, Cannon CP, Murphy SA, et al. Impact of trig|yceride levels beyond low-density lipoprotein cholesterol after acute coro- nary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardi- ol, 2008,51: 724-730.
  • 5Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/un- stable plaque. Arterioscler Thromb Vasc Biol, 2010,30 : 1282- 1292.
  • 6Ericsson CG, Hamsten A, Nilsson J, et al. An angiographic as- sessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet, 1996,347 : 849 -853.
  • 7Shah HD, Parikh KH, Chag MC, et al. Beneficial effects of the addition of fenofibrate to statin therapy in patients with acute cor- onary syndrome after percutaneous coronary interventions. Exp Clin Cardiol, 2007,12:91-96.
  • 8Sone H, Tanaka S, Tanaka S, et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes : subanaly- sis of the Japan diabetes complications study (JDCS). J Clin En- docrinol Metab, 2011,96:3448-3456.
  • 9Miller M, Stone N J, Ballantyne C, et al. Triglycerides and car- diovascular disease: a scientific statement from the American heart association. Circulation, 2011,123: 2292-2333.
  • 10中华医学会心血管病学分会循证医学评论专家组,中国老年学学会心脑血管病专业委员会.TG增高的血脂异常防治中国专家共识.实用糖尿病杂志,2012,8:13-16.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部